Bnp Paribas Asset Management Holding S.A. Ironwood Pharmaceuticals Inc Transaction History

Bnp Paribas Asset Management Holding S.A.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$8.99 - $10.74 $11.4 Million - $13.6 Million	-1,264,796 Closed	0 $0
Q2 2020 Aug 04, 2020	SELL	$9.14 - $11.97 $5.8 Million - $7.6 Million	-634,814 Reduced 33.42%	1,264,796 $13.1 Million
Q1 2020 May 12, 2020	SELL	$8.58 - $14.01 $39,631 - $64,712	-4,619 Reduced 0.24%	1,899,610 $19.2 Million
Q4 2019 Feb 11, 2020	BUY	$8.22 - $14.0 $4.21 Million - $7.17 Million	511,860 Added 36.76%	1,904,229 $25.3 Million
Q3 2019 Nov 12, 2019	BUY	$8.59 - $10.96 $4.76 Million - $6.07 Million	553,859 Added 66.05%	1,392,369 $12 Million
Q2 2019 Aug 02, 2019	BUY	$9.8 - $12.89 $1.77 Million - $2.33 Million	180,782 Added 27.49%	838,510 $9.17 Million
Q1 2019 Apr 26, 2019	BUY	$8.27 - $12.73 $1.32 Million - $2.03 Million	159,223 Added 31.94%	657,728 $8.9 Million
Q4 2018 Feb 13, 2019	SELL	$7.8 - $16.13 $5.34 Million - $11 Million	-684,118 Reduced 57.85%	498,505 $4.94 Million
Q3 2018 Nov 13, 2018	SELL	$14.31 - $17.65 $2.45 Million - $3.02 Million	-171,119 Reduced 12.64%	1,182,623 $21.8 Million
Q2 2018 Aug 01, 2018	SELL	$11.83 - $16.2 $4.16 Million - $5.69 Million	-351,232 Reduced 20.6%	1,353,742 $25.9 Million
Q1 2018 May 07, 2018	SELL	$11.13 - $13.63 $1.36 Million - $1.67 Million	-122,385 Reduced 6.7%	1,704,974 $26.3 Million
Q4 2017 Feb 01, 2018	BUY	$12.16 - $14.58 $168,549 - $202,093	13,861 Added 0.76%	1,827,359 $27.4 Million
Q3 2017 Nov 02, 2017	BUY	$12.07 - $14.87 $21.9 Million - $27 Million	1,813,498	1,813,498 $28.6 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.